Upamostat hydrogen sulfate - CAS 1191101-19-5

Upamostat, also known as Mesupron and WX-671, is an orally bioavailable second-generation serine protease inhibitor prodrug derived from 3-amidinophenylalanine. It targets the human urokinase plasminogen activator (uPA) system and exhibits potential antineoplastic and antimetastatic properties. After oral administration, the serine protease inhibitor WX-671 is converted into its active form, Nα- (2,4,6-triisopropylphenylsulfonyl) -3-amidinophenylalanine-4-ethoxycarbonylpiperazinylamide (WX-UK1), which inhibits multiple serine proteases, especially uPA, potentially hindering tumor growth and metastasis.

1191077

C32H49N5O10S2

727.89

S(=O)(=O)(O)O.S(N[C@H](C(=O)N1CCN(C(OCC)=O)CC1)CC2=CC(\C(=N/O)\N)=CC=C2)(=O)(=O)C3=C(C(C)C)C=C(C(C)C)C=C3C(C)C

-20°C

Ice Packs

Small Compound